Here are relevant reports on : ovulation-tests-market
-
Autoimmunity Diagnostics Market by Product (Consumables, Instruments), Test Type (Routine, Autoantibody, Inflammatory, Urinalysis Tests), Disease (RA, SLE, MS, IBD), End User (Clinical Laboratories, Hospitals & Clinics) - Global Forecast to 2031
The global autoimmunity diagnostics market, valued at US$5.26 billion in 2024, stood at US$5.57 billion in 2025 and is projected to advance at a resilient CAGR of 8.3% from 2025 to 2031, culminating in a forecasted valuation of US$8.98 billion by the end of the period. The autoimmunity diagnostics market is consistently growing, fueled by several key factors. These include the rising prevalence of autoimmune disease, growing awareness about early and accurate diagnosis, increasing research activities, and rapid advancements in diagnostic technologies.
- Published: July 2025
- Price: $ 4950
- TOC Available:
-
Animal Genetics Market by Live Animal (Bovine, Porcine, Canine), Products & Services (Genetic Materials (Semen, Embryo), Genetic Testing Services (Disease Tests, Trait Tests), Technology (PCR, NGS, rDNA), End User (Animal Farm) - Global Forecast to 2031
The global animal genetics market is projected to reach USD 9.37 billion by 2031, growing at a CAGR of 7.1% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Fertility Test Market by Product (Ovulation Predictor Kits, Fertility Monitors (Urine, Saliva, Blood)), Mode of Purchase (OTC, Prescription, Online), Application (Female, Male), End User (Home care, Fertility clinics, hospitals) & Region - Global Forecast to 2025
The global fertility test market growth is primed to transition from $472 million in 2020 to $680 million by 2025, showcasing a strong CAGR of 7.5%. Growth in this market is primarily driven by the increasing first-time pregnancy age in women, the declining fertility rate among men and women, the growing number of women suffering from disorders such as PCOS, the emergence of advanced ovulation monitors, and the increased awareness of fertility testing in both developed and developing countries.
- Published: April 2021
- Price: $ 4950
- TOC Available:
-
Asian Home Healthcare Market by Product (BP & Heart Rate Monitor, Ovulation KIT, HIV Test, ECG, EKG, EEG, Hearing Aids, Ventilator, Cane, Walker, Wheelchairs), Services (Rehabilitation, Skilled, Hospice, Palliative Care), & Telehealth - Global Forecast to 2020
The Asian home healthcare market size is projected to grow at a CAGR of 9.8%. The major factors driving the growth of this market include the rapidly increasing aging population, increasing incidences of chronic diseases, growing demand for affordable healthcare delivery systems due to increasing healthcare costs, technological advancements, and government initiatives to promote home healthcare. On the other hand, limited insurance coverage, lack of awareness about home healthcare, and patient safety concerns are major factors restricting the growth of this market.
- Published: March 2016
- Price: $ 4950
- TOC Available:
-
Poultry Diagnostics Market by Product Type (Consumable & Reagent, Instrument), Test Type (PCR, ELISA, Rapid Antigen Tests), Disease Type, Poultry Type (Broiler, Layer, Turkey, Duck & Geese), Sample Type (Swabs, Serum, Blood) - Global Forecast to 2031
The global poultry diagnostics market, valued at USD 0.17BN in 2025, stood at USD 0.18BN in 2026 and is projected to advance at a resilient CAGR of 7.1% from 2026 to 2031, culminating in a forecasted valuation of USD 0.25BN by the end of the period. The key players in the poultry diagnostics market include IDEXX Laboratories, Inc. (US), Zoetis Services LLC (US), Thermo Fisher Scientific Inc. (US), BioNote (South Korea), Innovative Diagnostics (France), Bio-Rad Laboratories, Inc. (US), BioChek (Netherlands), GD (Netherlands), INDICAL BIOSCIENCE GmbH (Germany), Shenzhen Bioeasy Biotechnology, Inc. (China), Ring Biotechnology Co., Ltd. (China), Bio-X Diagnostics S.A. (Belgium), MEGACOR Diagnostik GmbH (Austria), Gold Standard Diagnostics (Germany), and Bioneer Corporation (South Korea). These companies are recognized leaders in the field of poultry diagnostics.
- Published: March 2026
- Price: $ 4950
- TOC Available:
-
Respiratory Pathogen Detection Market by (Viral, Bacterial, Fungal), Technology (Polymerase Chain Reaction (PCR), Immunoassays, Nucleic Acid Amplification Tests (Naats), Mass Spectrometry, Others), End-User (Hospitals, Diagnostic Laboratories, Research Institutions) and Region - Global Forecast to 2030
The major players in the global Respiratory Pathogen Detection Market
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
IVD Reagents Market by Type (Antibodies, Nucleic Acid Probes), technology (Hematology), Application (Genetic Testing, Autoimmune disease), Test Type (Laboratory Test, Point-of-care Tests), End User (Hospitals & Clinics) & Region - Global Forecast to 2029
The global IVD reagents market, valued at US$57.29 billion in 2023, stood at US$60.45 billion in 2024 and is projected to advance at a resilient CAGR of 7.7% from 2024 to 2029, culminating in a forecasted valuation of US$87.41 billion by the end of the period. Growth in this market can be attributed to the rapidly increasing geriatric population in Asian countries and the increasing number of hospitals and clinical diagnostic laboratories.
- Published: December 2024
- Price: $ 4950
- TOC Available:
-
Biophotonics Market by Application(See-through Imaging, Inside Imaging, Spectromolecular, Surface Imaging, Microscopy, Light Therapy, Biosensors), Technology(In-vivo, In-vitro), End-use(Diagnostics, Therapeutic, Tests), & Geography - Global Growth Driver and Industry Forecast to 2035
The overall market for biophotonics in 2014 was valued at USD 26.26 Billion, which is estimated to reach USD 50.18 Billion by 2020, at a CAGR of 11.5% during the forecast period. This market growth can be attributed to emergence of nanotechnology, significant technological advancements over the last few years and their adoption in the medical sector, increase in the demand for home-based POC devices, aging population, and growing lifestyle diseases.
- Published: November 2026
- Price: $ 4950
- TOC Available:
-
Electronic Drug Delivery Systems Market by Type (Electronic Wearable Infusion Pump, Autoinjectors, Injection Pens, Electronic Inhalers), Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD) - Global Forecast to 2024
The electronic drug delivery system market is expected to grow from USD 7.8 billion in 2019 to USD 11.9 billion by 2024, at a compound annual growth rate (CAGR) of 8.7%. during the forecast period.The prominent players in the electronic drug delivery systems market are Insulet Corporation (US), Bayer AG (Germany), Medtronic (Ireland), Novo Nordisk A/S (Denmark), Companion Medical (US), F.Hoffmann-La Roche Ltd (Switzerland), United Therapeutics Corporation (US), AstraZeneca (UK), Tandem Diabetes Care (US), Merck Group (Germany), and Amgen (US).
- Published: October 2019
- Price: $ 4950
- TOC Available:
-
US Smart Cities Market by Focus Area (Transportation (Roadways, Railways, Airways), Buildings (Residential, Commercial, Industrial), Utilities (Energy, Gas, Water), Citizen Services) - Global Forecast to 2030
The US smart cities market is estimated to be USD 192.5 billion in 2025 and is projected to reach USD 374.0 billion by 2030, registering a CAGR of 14.2% during 2025–2030. The report profiles key players, such as Siemens (Germany), Cisco (US), Microsoft (US), IBM (US), Oracle (US), Sutherland (US), Hitachi (Japan), Honeywell (US), Verizon (US), Itron (US), AWS (US), Motorola (US), AT&T (US), KETOS (US), INRIX (US), Ubicquia, Inc (US), Schneider Electric (France), Quantela Inc. (US), Clarity Movement (US), and Iteris (US).
- Published: November 2026
- Price: $ 4950
- TOC Available:
Records 11 to 20 of 50
